Related references
Note: Only part of the references are listed.Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
Andrew Rhodes et al.
INTENSIVE CARE MEDICINE (2017)
Effect of Obesity on the Population Pharmacokinetics of Meropenem in Critically Ill Patients
Abdulaziz S. Alobaid et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
Mervyn Singer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Antibiotic Dosing in Patients With Acute Kidney Injury: Enough But Not Too Much
Susan J. Lewis et al.
JOURNAL OF INTENSIVE CARE MEDICINE (2016)
Population Pharmacokinetics and Monte Carlo Dosing Simulations of Meropenem during the Early Phase of Severe Sepsis and Septic Shock in Critically Ill Patients in Intensive Care Units
Sutep Jaruratanasirikul et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Meropenem Population Pharmacokinetics in Critically Ill Patients with Septic Shock and Continuous Renal Replacement Therapy: Influence of Residual Diuresis on Dose Requirements
Marta Ulldemolins et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Augmented Renal Clearance in the ICU: Results of a Multicenter Observational Study of Renal Function in Critically Ill Patients With Normal Plasma Creatinine Concentrations
Andrew A. Udy et al.
CRITICAL CARE MEDICINE (2014)
Mortality Related to Severe Sepsis and Septic Shock Among Critically III Patients in Australia and New Zealand, 2000-2012
Kirsi-Maija Kaukonen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions
Jason A. Roberts et al.
LANCET INFECTIOUS DISEASES (2014)
Assessment of pharmacokinetic changes of meropenem during therapy in septic critically ill patients
Joao Goncalves-Pereira et al.
BMC PHARMACOLOGY & TOXICOLOGY (2014)
Two general methods for population pharmacokinetic modeling: non-parametric adaptive grid and non-parametric Bayesian
Tatiana Tatarinova et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2013)
Pharmacokinetics of Meropenem in Critically Ill Patients With Severe Infections
Lutz Binder et al.
THERAPEUTIC DRUG MONITORING (2013)
Accurate Detection of Outliers and Subpopulations With Pmetrics, a Nonparametric and Parametric Pharmacometric Modeling and Simulation Package for R
Michael N. Neely et al.
THERAPEUTIC DRUG MONITORING (2012)
Meropenem Dosing in Critically Ill Patients with Sepsis Receiving High-Volume Continuous Venovenous Hemofiltration
I. Bilgrami et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution
Jason A. Roberts et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Meropenem - A review of its use in the treatment of serious bacterial infections
Claudine M. Baldwin et al.
DRUGS (2008)
Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections
Chonghua Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Comparative in vivo efficacy of meropenem, imipenem, and cefepime against Pseudomonas aeruginosa expressing MexA-MexB-OprM efflux pumps
Christine T. Ong et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2007)
Impact of sample size on the performance of multiple-model pharmacokinetic simulations
Vincent H. Tam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Prediction discrepancies for the evaluation of nonlinear mixed-effects models
France Mentre et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2006)
Antibacterial dosing in intensive care - Pharmacokinetics, degree of disease and pharmacodynamics of sepsis
Jason A. Roberts et al.
CLINICAL PHARMACOKINETICS (2006)
Pharmacokinetic evaluation of meropenem and imipenem in critically ill patients with sepsis
A Novelli et al.
CLINICAL PHARMACOKINETICS (2005)
Pharmacokinetics and pharmacodynamics of meropenern in febrile neutropenic patients with bacteremia
RE Ariano et al.
ANNALS OF PHARMACOTHERAPY (2005)
Pharmacokinetics and pharmacodynamics of meropenem in critically ill patients
R Kitzes-Cohen et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2002)
Share Paper
